Search
Friday 8 May 2015
  • :
  • :
Latest Update

Stocks on the Run - Fairchild Semiconductor International, (NASDAQ:FCS), Legg Mason, (NYSE:LM), Momenta Pharmaceuticals, (NASDAQ:MNTA), Nu Skin Enterprises, (NYSE:NUS)

On Friday, Shares of Fairchild Semiconductor International Inc. (NASDAQ:FCS), gained 4.32% to $18.95.

Fairchild Semiconductor International, declared that members of senior administration will attend the following investor conferences this quarter:

Baird Growth Stock Conference, Wednesday, May 6 held at The Four Seasons Hotel Chicago.

Mark Frey, Executive Vice President, Chief Financial Officer and Treasurer and Dan Janson, Vice President of Investor Relations, will speak.

Fairchild Semiconductor International, Inc. designs, develops, manufactures, and markets power analog, power discrete, and non-power semiconductor solutions worldwide. It operates through three segments: Mobile, Computing, Consumer, and Communication (MCCC); Power Conversion, Industrial, and Automotive (PCIA); and Standard Discrete and Standard Linear (SDT).

At the end of Friday’s trade, Shares of Legg Mason Inc. (NYSE:LM), jumped 4.25% to $54.89.

Legg Mason, stated its operating results for the fourth fiscal quarter and fiscal year-ended March 31, 2015. The Company stated net income of $83.0 million, or $0.73 per diluted share, as contrast to $77.0 million, or $0.67 per diluted share, in the previous quarter, and net income of $68.9 million, or $0.58 per diluted share, in the fourth quarter of fiscal 2014. Adjusted income for the fourth fiscal quarter was $117.9 million, or $1.03 per diluted share, as contrast to $113.1 million, or $0.98 per diluted share, in the previous quarter and $103.5 million, or $0.86 per diluted share, in the fourth quarter of fiscal 2014. For the current quarter, operating revenues were $702.3 million, down 2% from $719.0 million in the preceding quarter, and up 3% contrast to $681.4 million in the fourth quarter of fiscal 2014. Operating expenses were $573.4 million, down 4% from $599.6 million in the preceding quarter, and up 2% contrast to $562.1 million in the fourth quarter of fiscal 2014.

Net income for fiscal year 2015 was $237.1 million, or $2.04 per diluted share, as contrast to net income of $284.8 million, or $2.33 per diluted share, for fiscal year 2014. In fiscal 2015, Legg Mason accomplished a debt refinancing that resulted in a $107.1 million charge, or $0.59 per diluted share. Adjusted income for the year was $378.8 million, or $3.26 per diluted share, as contrast to adjusted income of $417.8 million, or $3.41 per diluted share for fiscal year 2014. Operating revenues for fiscal year 2015 were $2.8 billion, up 3% from $2.7 billion for fiscal year 2014. Operating expenses for fiscal year 2015 of $2.3 billion were flat contrast to fiscal year 2014.

Legg Mason, Inc. is a publicly owned asset administration holding company. The firm provides investment administration and related services to institutional and individual clients, company-sponsored mutual funds and other pooled investment vehicles through its wholly owned auxiliaries. Legg Mason, Inc. was founded in 1899 and is based in Baltimore, Maryland.

Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), ended its last trade with 4.18% gain, and closed at $18.18.

Momenta Pharmaceuticals, declared that its presentation at the Deutsche Bank 40th Annual Health Care Conference will be webcast on Thursday, May 7, 2015 at 2:10 p.m. ET.

Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune diseases.

Finally, Nu Skin Enterprises Inc. (NYSE:NUS), closed at $58.91, with 4.17% gain.

Nu Skin Enterprises, will release first-quarter 2015 results after the market close on Wednesday, May 6. The Nu Skin administration team will host a conference call with the investment community later that same day at 5 p.m. (EDT). During the call, participants will hear administration talk about past results and forthcoming business initiatives.

Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex brands worldwide. The company offers skin-care systems and treatment products, such as ageLOC Spa systems, ageLOC Tru Face Essence Ultra anti-aging skin care serum, and ageLOC Transformation anti-aging skin care system, in addition to other cosmetic, personal care, and hair care products.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *